*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Empagliflozin</strong> (CAS 864070-44-0, C21H25NO8) is a potent selective SGLT2 inhibitor synthesized via multi-step organic coupling. It functions by blocking renal glucose reabsorption.</p>
<h3>Application</h3>
<ul>
<li>Treatment of type 2 diabetes mellitus to lower blood glucose levels.</li>
<li>Management of heart failure with reduced ejection fraction.</li>
<li>Chronic kidney disease progression delay in high-risk patients.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in severe renal impairment or dialysis. Store at controlled room temperature (20-25°C) away from moisture. Handle with PPE due to potential respiratory sensitization.</p>